Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Earnings symbols : QGEN save search
QIAGEN Announces Form 20-F Annual Report Filing for 2022 Results
Published: 2023-03-13 (Crawled : 13:00) - biospace.com/
QGEN | $39.47 0.61% 0.0% 950K
|
Health Technology
|
| O: 1.2%
H: 0.56%
C: -0.15%
QGEN | $39.47 0.61% 0.0% 950K
|
Health Technology
|
| O: 1.2%
H: 0.56%
C: -0.15%
report
QIAGEN N.V. to Release Results for Q4 and Full-Year Results 2022 and Hold Webcast
Published: 2023-01-17 (Crawled : 13:00) - biospace.com/
QGEN | $39.47 0.61% 0.0% 950K
|
Health Technology
|
| O: 0.38%
H: 0.2%
C: -1.04%
QGEN | $39.47 0.61% 0.0% 950K
|
Health Technology
|
| O: 0.38%
H: 0.2%
C: -1.04%
QIAGEN N.V. to Release Results for Q3 2022 and Hold Webcast
Published: 2022-10-21 (Crawled : 12:00) - biospace.com/
QGEN | $39.47 0.61% 0.0% 950K
|
Health Technology
|
| O: -0.54%
H: 0.78%
C: 0.21%
QGEN | $39.47 0.61% 0.0% 950K
|
Health Technology
|
| O: -0.54%
H: 0.78%
C: 0.21%
QIAGEN beats outlook for fourth quarter and full-year 2021, delivers 22% CER full-year sales growth from non-COVID products
Published: 2022-02-08 (Crawled : 00:00) - biospace.com/
QGEN | $39.47 0.61% 0.0% 950K
|
Health Technology
|
| O: -2.57%
H: 0.0%
C: 0.0%
QGEN | $39.47 0.61% 0.0% 950K
|
Health Technology
|
| O: -2.57%
H: 0.0%
C: 0.0%
sales liver covid growth
QIAGEN N.V. to Release Results for Q3 2021 and First Nine Months of 2021
Published: 2021-10-20 (Crawled : 19:00) - biospace.com/
QGEN | $39.47 0.61% 0.0% 950K
|
Health Technology
|
| O: 1.41%
H: 0.26%
C: -0.23%
QGEN | $39.47 0.61% 0.0% 950K
|
Health Technology
|
| O: 1.41%
H: 0.26%
C: -0.23%
results
QIAGEN announces preliminary Q2 2021 results exceeding outlook, updates full-year 2021 outlook for declining COVID-19 test trends and plans new $100 million share repurchase program
Published: 2021-07-12 (Crawled : 19:00) - biospace.com/
QGEN | $39.47 0.61% 0.0% 950K
|
Health Technology
|
| O: 1.37%
H: 0.33%
C: -4.73%
QGEN | $39.47 0.61% 0.0% 950K
|
Health Technology
|
| O: 1.37%
H: 0.33%
C: -4.73%
covid test results
QIAGEN Exceeds Outlook in First Quarter 2021 Results, Reaffirms Sales Growth and Profitability Outlook for Full-Year 2021
Published: 2021-05-03 (Crawled : 22:00) - biospace.com/
QGEN | $39.47 0.61% 0.0% 950K
|
Health Technology
|
| O: 1.02%
H: 0.23%
C: -2.06%
QGEN | $39.47 0.61% 0.0% 950K
|
Health Technology
|
| O: 1.02%
H: 0.23%
C: -2.06%
sales results growth
QIAGEN N.V. to Report First Quarter 2021 Results
Published: 2021-04-20 (Crawled : 11:00) - biospace.com/
QGEN | $39.47 0.61% 0.0% 950K
|
Health Technology
|
| O: -0.97%
H: 0.64%
C: 0.6%
QGEN | $39.47 0.61% 0.0% 950K
|
Health Technology
|
| O: -0.97%
H: 0.64%
C: 0.6%
results
QIAGEN Announces 20-F Annual Report Filing for 2020 Results
Published: 2021-03-05 (Crawled : 12:00) - biospace.com/
QGEN | $39.47 0.61% 0.0% 950K
|
Health Technology
|
| O: -0.92%
H: 1.34%
C: 0.81%
QGEN | $39.47 0.61% 0.0% 950K
|
Health Technology
|
| O: -0.92%
H: 1.34%
C: 0.81%
results
Gainers vs Losers
| 59% | 41% |
Top 10 Gainers
AGBA | News | $1.03 157.5% 57.94% 120M
|
Finance
ZCMD | $1.45 5.84% 52.1% 2.3M
|
Commercial Services
INVO | $1.52 100.0% 51.13% 5M
|
Health Technology
ISPC | $0.421 97.65% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.5 45.65% 470K
|
OST | $0.509 23.81% 45.26% 90K
|
GDHG | $0.263 21.76% 40.66% 3.1M
|
XPON | News | $3.15 63.21% 37.74% 16M
|
TIRX | $0.8 65.02% 30.74% 58M
|
BNTC | News | $6.82 42.08% 30.64% 3.5M
|
Health Technology
Your saved searches
Save your searches and get alerts when important news are released.